Alembic Pharma share price surged after the USFDA issued establishment inspection report (EIR) for the inspection carried out at the company’s Oral Solid Formulation Facility (F-I).
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
